High Tower Advisors, LLC Pfizer Inc Call Options Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $15,156 - $17,760	600 Added 60.0%	1,600 $44,000
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $25,890 - $29,730	1,000 New	1,000 $27,000
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $165,438 - $215,376	4,200 New	4,200 $171,000
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $6,607 - $7,834	-142 Reduced 41.52%	200 $2,000
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $12,444 - $15,419	272 Added 388.57%	342 $112,000
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $1.98 Million - $2.52 Million	-59,230 Reduced 99.88%	70 $11,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $542,925 - $636,975	17,100 Added 40.52%	59,300 $40,000
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $487,944 - $591,948	16,200 Added 62.31%	42,200 $24,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $823,000 - $934,000	25,000 Added 2500.0%	26,000 $12,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $37,500 - $41,200	1,000 New	1,000 $1,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.